News

MedPage Today on MSN6dOpinion
Vinay Prasad Speaks to CBER Staff: Which Prasad Showed Up?
The question on many minds among FDA rank-and-file in attendance was: Which Prasad would show up? The 2010s Prasad -- a ...
FDA chooses Dr. Vinay Prasad to lead biologics, vaccines division
The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...
FDA names Dr. Vinay Prasad as top vaccine official
In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...
Who Is Vinay Prasad? RFK Jr. Taps Pharma Critic to Lead FDA Vaccine Program
Prasad's appointment marks the latest addition of a medical skeptic and critics of COVID-19 policies to federal health ...
Science-Based Medicine6dOpinion
Dr. Vinay Prasad is Now the Medical Establishment. It’s His Job to Run RCTs, and It’s Our Job to Call Him a Lying Piece of $#!& if He Fails.
From claiming COVID vaccines were perfect and would end the pandemic to treating rare, temporary vaccine side-effects, even ...
US FDA names agency critic Vinay Prasad as top vaccine official
The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and ...
FDA Names Vinay Prasad as New Head of Vaccines, Biologics
FDA Commissioner Marty Makary named Vinay Prasad, a hematologist oncologist and critic of the Covid-19 vaccine for children, ...
Vinay Prasad, a critic of drug industry and COVID-19 measures, to lead FDA vaccine program
Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to ...
HealthDay on MSN3d
Dr Vinay Prasad to Head FDA Vaccine, Biologics Division
The United States Food and Drug Administration has chosen Dr Vinay Prasad to lead its Center for Biologics Evaluation and Research.
STAT8d
Vinay Prasad, in his own words, outlines the philosophy he’ll bring to the FDA
Not Vinay Prasad. The new top regulator of vaccines and gene therapies at the Food and Drug Administration has never shied ...
BioPharma Dive7d
Biotech is guessing how Vinay Prasad might change the FDA. His research, writing offer clues.
CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might ...
Bloomberg L.P.2d
FDA Appointee Is a Notorious Drug Critic With a Lot to Prove
Previously, she was executive editor of Chemical & Engineering News. The controversial appointment of oncologist Vinay Prasad — an outspoken critic of the pharmaceutical industry and US health ...